Skip to main content

Unaided Sharp and Continuous Vision in All Daily Activities

Project description

New implant to treat cataracts

With age comes… cataracts. Very common in older people, cataracts cause clouding of the eye's lens, affecting vision. Despite innovations in the domain of ophthalmological implants, called intraocular lenses, cataract patients do not regain sharp and continuous vision. New ophthalmic implants patented by France’s Cristalens Industrie could reverse this trend. The EU-funded SYMBIOSE project will validate this new implant to prepare for its commercialisation. Specifically, the project will collect enough data to demonstrate high performance by testing on several hundred patients. The project will also prepare for scaling up production and support the wide distribution of the products.

Call for proposal


See other projects for this call

Sub call



Net EU contribution
€ 1 598 459,00
4 Rue Louis De Broglie
22300 Lannion

See on map

Bretagne Bretagne Côtes-d’Armor
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Other funding
€ 685 069,75